Phase 2 Glomerulonephritis, IGA Clinical Trials

2 recruitingPhase 2

What is a Phase 2 trial?

Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.

Showing 1–2 of 2 trials

Recruiting

Phase 2

A Study of the Safety and Activity of Sparsentan for the Treatment of Patients With Immunoglobulin A Nephropathy

Kidney DiseasesImmune System DiseasesAutoimmune Diseases+3 more

University of Leicester24 enrolled6 locationsNCT04663204

Recruiting

Phase 2

Study to Evaluate the Impact of Iptacopan on Top of SOC on Biopsy Changes in Kidneys of Adult Patients With IgAN

Glomerulonephritis, IGAImmunoglobulin A Nephropathy

Novartis Pharmaceuticals20 enrolled18 locationsNCT06797518